THE ROLE OF GENETICALLY ENGINEERED BIOLOGICAL AGENTS AND PROINFLAMMATORY CYTOKINES IN THE PATHOGENETIC MECHANISMS OF THE CORONAVIRUS INFECTION (COVID-19)
Relevance: The similarity of the pathogenetic mechanisms of coronavirus infection (COVID-19) with autoimmune processes determinared the widespread use of genetically engineered biological drugs (GEBD) in the treatment of COVID-19. The current knowledge on the role of proinflammatory cytokines as interleukins (IL)1, 6 and inhibitors of tumor necrosis factor-α (TNF-α) is summarized, including their involvement into the pathogenetic mechanisms of coronavirus infection. Based on data of recent studies, we generalized the results of using GEBD in the treatment of varying severity COVID-19 and highlighted the features of their applying. The results of the "repositioned" biological drugs for the COVID-19 therapy were analyzed, and the practical experience of the appointment during the pandemic (including clinical studies) were reflected.
Aim: Analysis of literature related to on the experience of the international use of genetic engineering drugs in the treatment of coronavirus infection of varying severity.
Search strategy: The literature search was carried out using PubMed, GoogleScholar and Medline databases over the last 3 years. Medline databases over the past 3 years, and several sources from 1996. 2001 and 2009 containing conceptual information were also included. Inclusion criteria were reports on randomized and cohort studies, meta-analyses, systematic reviews, original full-text articles in English and Russian that are in the public domain and contain statistically confirmed findings. Exclusion criteria: brief reports, newspaper articles and personal communications.
Results: Based on the results of our review, many studies indicate a correlation between increased levels of pro-inflammatory markers such as interleukin (IL)6, IL8, IL10, IL2R, tumor necrosis factor α (TNF-α) and the severity of the COVID- 19. Despite on the widespread use of various mechanisms GEBD drugs with in the fight against the pandemic, the greatest effectiveness was demonstrated by IL-6 blockers/
Number of Views: 149
Category of articles:
COVID-19 - Topical Subject
Bibliography link
Rutskaya-Moroshan K.S., Abisheva S.T., Vinnik T.V., Aubakirova B.A., Ajtkazina А.Т., Аbіsheva A.B., Rebrikov P.I. The role of genetically engineered biological agents and proinflammatory cytokines in the pathogenetic mechanisms of the coronavirus infection (COVID-19) // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 4, pp. 13-23. doi 10.34689/SH.2023.25.4.002Related publications:
EPIDEMIOLOGICAL ASPECTS OF IN-STENT THROMBOSIS AND RESTENOSIS OF CORONARY ARTERIES IN PATIENTS WITH PREVIOUS REVASCULARIZATION AFTER CORONAVIRUS INFECTION
IMMUNOLOGICAL CHANGES IN CHILDREN WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-COV-2
EFFICACY OF THE ANTIVIRAL DRUG ENISAMY IODIDE IN SEVERE ADULT ACUTE RESPIRATORY INFECTIONS IN THE COVID-19 ERA
APPLICATION OF ARTIFICIAL INTELLIGENCE IN COMBATING THE COVID-19 PANDEMIC: CURRENT TRENDS AND PROSPECTS. REVIEW
CONSEQUENCES OF THE CORONAVIRUS INFECTION: THE POST-COVID SYNDROME AND MENTAL MANIFESTATIONS. LITERATURE REVIEW